InvestorsHub Logo
Followers 46
Posts 1362
Boards Moderated 0
Alias Born 08/09/2015

Re: McMagyar post# 81918

Sunday, 12/04/2016 9:38:15 AM

Sunday, December 04, 2016 9:38:15 AM

Post# of 459498
Dose optimization: I remember that Missling said that the AVXL 2-73 was yet to be optimized. This factor could result in improved results in the future trial assuming safety is maintained with increased dosage. I am interested in knowing more about this and perhaps other things that have been learned to improve benefits -- besides mono-therapy?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News